147 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
22 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
23 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
24 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
25 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
26 Recruiting Treatment of Brain AVMs (TOBAS) Study
Conditions: Unruptured Brain Arteriovenous Malformation;   Ruptured Brain Arteriovenous Malformation;   Arteriovenous Malformations;   AVM;   BAVM
Interventions: Procedure: Neurosurgery;   Radiation: Radiation therapy;   Procedure: Embolization
27 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
28 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
29 Unknown  Assessing the Effects of Air-cooling on Capillary Malformations
Conditions: Capillary Malformation;   Laser;   Skin Cooling
Intervention: Device: Air cooling to CM site
30 Recruiting Effect of Laser Treatment on Capillary Malformations
Conditions: Capillary Malformation;   Port Wine Stain
Intervention:
31 Recruiting Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery
Condition: Intracranial Arteriovenous Malformations
Interventions: Procedure: fMRI Navigation AVM resection;   Procedure: conventional resection
32 Recruiting MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Conditions: Cerebral Hemorrhage;   Intracranial Arteriovenous Malformations;   Intracranial Hemorrhage, Hypertensive;   Brain Neoplasms
Intervention: Device: MRI Scan with the specified sequences below:
33 Recruiting Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China
Condition: Intracranial Arteriovenous Malformations
Intervention:
34 Recruiting ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)
Condition: Cerebral Arteriovenous Malformations
Intervention:
35 Completed Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
Conditions: Aneurysms;   Arteriovenous Malformations
Interventions: Drug: minocycline;   Drug: doxycycline
36 Unknown  Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention: Drug: Simvastatin
37 Unknown  Modifiers of Disease Severity in Cerebral Cavernous Malformations
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention: Other: Natural history data collection
38 Not yet recruiting Regional Anesthesia for Arteriovenous Fistula
Condition: Arteriovenous Fistula
Interventions: Procedure: Axillary Block with 0.5% Ropivicaine;   Procedure: Stellate ganglion block with 0.2% Ropivicaine;   Procedure: Local anesthetic infiltration with 0.25% Bupivicaine
39 Unknown  Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
40 Unknown  Diet and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia (HHT)
Interventions: Other: Questionnaire on dietary history;   Other: Questionnaire on nosebleed severity;   Other: One week food diary generated by weighing foods;   Procedure: Blood tests for full blood count, albumin, and indices of nutritional status

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years